Abstract. The isolated perfused duck pancreas was used to study the effect of free fatty acids (FFA) on pancreatic function in vitro and to determine whether the FFA-glucagon negative feedback mechanism resulted from a direct inhibitory effect of FFA on the pancreatic A cell. Oleate, 2 mmol/l, increased the output rates of pancreatic somatostatin, glucagon and insulin. As there is poor morphological evidence in the duck for somatostatin to act as a paracrine intra-islet modulator, we reproduced in the pancreatico-duodenal artery, the rise in somatostatin level obtained in the pancreatic effluent after oleate. In these conditions the rises in glucagon and insulin secretions after oleate treatment were, respectively, reversed and suppressed, thereby reproducing observations previously made in vivo. Consequently, we may assume that the negative FFA-glucagon feedback mechanism that operates in vivo for physiological FFA variations does not result from a direct effect of FFA on the A cell, but may rather be mediated by an increase in pancreatic somatostatin secretion.
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Glucagon is known to belong to the class of lipoly¬ tic hormones in vertebrates. In mammals its lipo¬ lytic effect has been shown both in vitro (Vaughan 1960) and in vivo (Lefebvre 1966) . On the other hand, FFA decrease glucagon secretion in vivo (Seyffert & Madison 1967) and in vitro (Edwards & Taylor 1970) .
In birds, glucagon is a very potent lipolytic hormone (Heald et al. 1965) ; this is true in the duck (Desbals 1972) Effect of somatostatin (1.9 then 3.8 nmol/l) on oleate effect (Fig. 3 (Laurent 1983 ). Indeed, somatostatin previously shown to inhibit insulin secretion in the duck (Strosser et al. 1980), when given simultaneously with oleate suppresses the rise in insulin output. 
